Bionoia Where life meets thought ⌕
Back to Journal
Journal › Mucosa
Microbiome interface

Butyrate and SCFAs — the central fuel

Hypothesis Mechanism review
butyrate scfa microbiome barrier goblet cells supplement mechanism
Editor's note
Butyrate's role extends far beyond simple fuel—it actively orchestrates barrier repair and immune tolerance through goblet cell programming and tight junction stability, making microbial metabolism foundational to mucosal health rather than merely supportive. This bridges an important gap between microbiome science and barrier physiology, though causality in human disease remains incompletely mapped. Gastroenterologists managing IBD and mucositis, alongside researchers studying barrier dysfunction and dysbiosis, should integrate these mechanistic insights into dietary and therapeutic strategies.

Goblet cells and colonocytes run on butyrate as primary energy source. This is not incidental.

Butyrate serves as a key energy substrate for goblet cells producing MUC2 and protects intestinal barrier integrity. It increases expression of trefoil factor (TFF), which helps maintain and repair mucin-related peptides. It modulates expression of tight junction proteins, reducing paracellular permeability.

Butyrate also increases mucin production and the proportion of mucin-secreting goblet cells in the colonic crypt in a macrophage-dependent manner. Adoptive transfer of butyrate-induced M2 macrophages facilitated goblet cell generation and mucus restoration after DSS damage.

Practical: Butyrate is produced by microbial fermentation of fiber, especially resistant starch and β-glucan (oats, cooked-and-cooled potato/rice, green banana, legumes). Direct butyrate supplements (sodium butyrate, calcium butyrate, often enterocoated/sustained release) are used in mucositis and IBD maintenance. Rectal butyrate administration has clinical history in UC.

Related articles in this corpus

Extends
Trefoil factors (TFF1, TFF2, TFF3) — the active repair system
Article B identifies trefoil factors as the specific molecular mechanism by which butyrate (from Article A) protects intestinal barrier integrity and maintains tight junction function.
Extends
MUC2 glycosylation — the structural key
Article B identifies butyrate as the metabolic fuel that enables the goblet cells to produce the structurally complex, heavily glycosylated MUC2 molecules described in Article A.
Extends
The mucin barrier — architecture
Article B describes the structural architecture of the mucin barrier that Article A explains is built and maintained through butyrate-driven goblet cell function and MUC2 production.
Extends
The integrated mechanistic model
Article B builds on Article A's mechanistic foundation by proposing that butyrate's protective effects on goblet cell function and mucin production become pathologically insufficient when defective mucin glycosylation creates a self-reinforcing loop of bacterial encroachment and mucosal disease.
Extends
Microbiota-derived butyrate inhibits colonic epithelial pyroptosis and mitigates DSS-induced colitis via interacting with aryl hydrocarbon receptor
Article B mechanistically extends Article A by identifying the aryl hydrocarbon receptor (AhR) pathway as a specific molecular mechanism through which butyrate protects intestinal barrier integrity and prevents colonic inflammation.
Published 2026-05-24 · Last kit-update 2026-05-24